← Back to Search

Clinical Decision Support Tool

Extubation Advisor for Extubation

Phase 1

Recruiting

Led By Andrew JE Seely, MD, PhD, FRCSC

Research Sponsored by Ottawa Hospital Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up upon study completion, 4 months after study initiation

Awards & highlights

Study Summary

This trial is assessing the feasibility of a new tool, the Extubation Advisor, to help with the decision of when to extubate a patient in the ICU.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ upon study completion, 4 months after study initiation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~upon study completion, 4 months after study initiation

This trial's timeline: 3 weeks for screening, Varies for treatment, and upon study completion, 4 months after study initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evaluate feasibility of capturing greater than 75% of wave form data

Evaluate feasibility of enrolling and consenting greater than 50% of eligible patients

Evaluate feasibility of entering greater than 90% of participant clinical data into the Extubation Advisor tool

+2 more

Secondary outcome measures

Evaluate feasibility of completing greater than 90% of clinical CRFs

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention ArmExperimental Treatment1 Intervention

Wave form data from participants' spontaneous breathing trials (SBT) will be analyzed using Extubation Advisor (EA) to generate an EA report that provides clinical decision support regarding extubation.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor

561 Previous Clinical Trials

2,785,619 Total Patients Enrolled

2 Trials studying Extubation

720 Patients Enrolled for Extubation

Andrew JE Seely, MD, PhD, FRCSCPrincipal InvestigatorThe Ottawa Hospital

1 Previous Clinical Trials

140 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate number of participants included in this research project?

"Affirmative. An inspection of the clinicaltrials.gov website reveals that this trial, which was initially published on October 4th 2021, is currently recruiting patients. The desired number of participants at one site totals 72 individuals."

Answered by AI

What possible hazards exist when using Extubation Advisor?

"Our organisation has assigned the AI-driven medical tool Extubation Advisor a score of 1 on a scale from low to high risk due to it being in its initial phase and having limited research conducted on both safety and efficacy."

Answered by AI

Are researchers actively seeking participants for this experiment?

"According to the details available on clinicaltrials.gov, this research trial is currently open for recruitment and was initially posted in October 2021 while its most recent update occurred in September of 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool

2021. "Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04708509.